What We're Reading: Page 2
Industry reads hand-picked by our editors
Jan 12, 2026
Jan 09, 2026
-
The Financial Times
Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn
-
The Boston Globe
‘A little bit more certainty’: After shaky years, Mass. life science companies find glimmers of hope
-
CNBC
A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year
Jan 08, 2026
Jan 07, 2026
-
CNBC
Big Pharma race to snap up biotech assets as $170 billion patent cliff looms
-
The Wall Street Journal
Eli Lilly Nears Deal for Biotech Ventyx
-
The Washington Post
CDC staff ‘blindsided’ as child vaccine schedule unilaterally overhauled
-
Axios
Why drug prices will keep rising through Trump’s second term
Jan 06, 2026
Jan 05, 2026
Dec 23, 2025
-
Science
Will NIH’s new director reform his agency—or destroy it?
-
The Atlantic
I Bought ‘GLP-3’
-
The Wall Street Journal
Your Brain Ages in Five Distinct Stages, New Research Shows
-
Reuters
J&J vows appeal after US jury hits it with record $1.5 billion talc cancer award
Previous
